US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

Clinical Trial Market Research Reports & Industry Analysis

RSS Feeds

Clinical Trial Industry Research & Market Reports

6  7  8  9    11    13  14  15  
Community-Acquired Bacterial Pneumonia-Pipeline Insights, 2015
4/6/2015 | published by: DelveInsight
... pipeline drugs that fall under Community-Acquired Bacterial Pneumonia. The report provides information on the therapeutic development based on the Community-Acquired Bacterial Pneumonia providing licensing, chemical, technology information and comparative analysis at various stages. DelveInsight’s Report ...  |  read more...
USD 1,250
Condyloma-Pipeline Insights, 2015
4/6/2015 | published by: DelveInsight
... under Condyloma. The report provides information on the therapeutic development based on the Condyloma providing licensing, chemical, technology information and comparative analysis at various stages. DelveInsight’s Report is assessing the Condyloma therapeutics by Monotherapy, Combination ...  |  read more...
USD 1,250
Constipation-Pipeline Insights, 2015
4/6/2015 | published by: DelveInsight
... under Constipation. The report provides information on the therapeutic development based on the Constipation providing licensing, chemical, technology information and comparative analysis at various stages. DelveInsight’s Report is assessing the Constipation therapeutics by Monotherapy, Combination ...  |  read more...
USD 1,250
Diarrhea-Pipeline Insights, 2015
4/6/2015 | published by: DelveInsight
... under Diarrhea. The report provides information on the therapeutic development based on the Diarrhea providing licensing, chemical, technology information and comparative analysis at various stages. DelveInsight’s Report is assessing the Diarrhea therapeutics by Monotherapy, Combination ...  |  read more...
USD 1,250
Diphtheria-Pipeline Insights, 2015
4/6/2015 | published by: DelveInsight
... under Diphtheria. The report provides information on the therapeutic development based on the Diphtheria providing licensing, chemical, technology information and comparative analysis at various stages. DelveInsight’s Report is assessing the Diphtheria therapeutics by Monotherapy, Combination ...  |  read more...
USD 1,250
Down Syndrome-Pipeline Insights, 2015
4/6/2015 | published by: DelveInsight
... that fall under Down Syndrome. The report provides information on the therapeutic development based on the Down Syndrome providing licensing, chemical, technology information and comparative analysis at various stages. DelveInsight’s Report is assessing the Down ...  |  read more...
USD 1,250
Duchenne Muscular Dystrophy-Pipeline Insights, 2015
4/6/2015 | published by: DelveInsight
... pipeline drugs that fall under Duchenne Muscular Dystrophy. The report provides information on the therapeutic development based on the Duchenne Muscular Dystrophy providing licensing, chemical, technology information and comparative analysis at various stages. DelveInsight’s Report ...  |  read more...
USD 1,250
Dyskinesia-Pipeline Insights, 2015
4/6/2015 | published by: DelveInsight
... under Dyskinesia. The report provides information on the therapeutic development based on the Dyskinesia providing licensing, chemical, technology information and comparative analysis at various stages. DelveInsight’s Report is assessing the Dyskinesia therapeutics by Monotherapy, Combination ...  |  read more...
USD 1,250
Dysmenorrhea-Pipeline Insights, 2015
4/6/2015 | published by: DelveInsight
... under Dysmenorrhea. The report provides information on the therapeutic development based on the Dysmenorrhea providing licensing, chemical, technology information and comparative analysis at various stages. DelveInsight’s Report is assessing the Dysmenorrhea therapeutics by Monotherapy, Combination ...  |  read more...
USD 1,250
Familial Chylomicronemia (Type I Hyperlipoproteinemia)-Pipeline Insights, 2015
4/6/2015 | published by: DelveInsight
... understanding for all the pipeline drugs that fall under Familial Chylomicronemia (Type I Hyperlipoproteinemia). The report provides information on the therapeutic development based on the Familial Chylomicronemia (Type I Hyperlipoproteinemia) providing licensing, chemical, technology information ...  |  read more...
USD 1,250
Familial Hypercholesterolemia (Type II Hyperlipoproteinemia)-Pipeline Insights, 2015
4/6/2015 | published by: DelveInsight
... understanding for all the pipeline drugs that fall under Familial Hypercholesterolemia (Type II Hyperlipoproteinemia). The report provides information on the therapeutic development based on the Familial Hypercholesterolemia (Type II Hyperlipoproteinemia) providing licensing, chemical, technology information ...  |  read more...
USD 1,250
Hemorrhagic Fever-Pipeline Insights, 2015
4/6/2015 | published by: DelveInsight
... that fall under Hemorrhagic Fever. The report provides information on the therapeutic development based on the Hemorrhagic Fever providing licensing, chemical, technology information and comparative analysis at various stages. DelveInsight’s Report is assessing the Hemorrhagic ...  |  read more...
USD 1,250
Hemorrhagic Shock-Pipeline Insights, 2015
4/6/2015 | published by: DelveInsight
... that fall under Hemorrhagic Shock. The report provides information on the therapeutic development based on the Hemorrhagic Shock providing licensing, chemical, technology information and comparative analysis at various stages. DelveInsight’s Report is assessing the Hemorrhagic ...  |  read more...
USD 1,250
Hepatic Encephalopathy-Pipeline Insights, 2015
4/6/2015 | published by: DelveInsight
... that fall under Hepatic Encephalopathy. The report provides information on the therapeutic development based on the Hepatic Encephalopathy providing licensing, chemical, technology information and comparative analysis at various stages. DelveInsight’s Report is assessing the Hepatic ...  |  read more...
USD 1,250
Hepatitis A-Pipeline Insights, 2015
4/6/2015 | published by: DelveInsight
... that fall under Hepatitis A. The report provides information on the therapeutic development based on the Hepatitis A providing licensing, chemical, technology information and comparative analysis at various stages. DelveInsight’s Report is assessing the Hepatitis ...  |  read more...
USD 1,250
Herpes Simplex Infections-Pipeline Insights, 2015
4/6/2015 | published by: DelveInsight
... pipeline drugs that fall under Herpes Simplex Infections. The report provides information on the therapeutic development based on the Herpes Simplex Infections providing licensing, chemical, technology information and comparative analysis at various stages. DelveInsight’s Report ...  |  read more...
USD 1,250
High Triglyceridemia-Pipeline Insights, 2015
4/6/2015 | published by: DelveInsight
... that fall under High Triglyceridemia. The report provides information on the therapeutic development based on the High Triglyceridemia providing licensing, chemical, technology information and comparative analysis at various stages. DelveInsight’s Report is assessing the High ...  |  read more...
USD 1,250
Hirsutism-Pipeline Insights, 2015
4/6/2015 | published by: DelveInsight
... under Hirsutism. The report provides information on the therapeutic development based on the Hirsutism providing licensing, chemical, technology information and comparative analysis at various stages. DelveInsight’s Report is assessing the Hirsutism therapeutics by Monotherapy, Combination ...  |  read more...
USD 1,250
HIV-2 Infection-Pipeline Insights, 2015
4/6/2015 | published by: DelveInsight
... that fall under HIV-2 Infection. The report provides information on the therapeutic development based on the HIV-2 Infection providing licensing, chemical, technology information and comparative analysis at various stages. DelveInsight’s Report is assessing the HIV-2 ...  |  read more...
USD 1,250
Hot Flashes-Pipeline Insights, 2015
4/6/2015 | published by: DelveInsight
... that fall under Hot Flashes. The report provides information on the therapeutic development based on the Hot Flashes providing licensing, chemical, technology information and comparative analysis at various stages. DelveInsight’s Report is assessing the Hot ...  |  read more...
USD 1,250
House Dust Mite Allergy-Pipeline Insights, 2015
4/6/2015 | published by: DelveInsight
... all the pipeline drugs that fall under House Dust Mite Allergy. The report provides information on the therapeutic development based on the House Dust Mite Allergy providing licensing, chemical, technology information and comparative analysis at ...  |  read more...
USD 1,250
Humoral Hypercalcemia of Malignancy-Pipeline Insights, 2015
4/6/2015 | published by: DelveInsight
... all the pipeline drugs that fall under Humoral Hypercalcemia of Malignancy. The report provides information on the therapeutic development based on the Humoral Hypercalcemia of Malignancy providing licensing, chemical, technology information and comparative analysis at ...  |  read more...
USD 1,250
Hyperalgesia-Pipeline Insights, 2015
4/6/2015 | published by: DelveInsight
... under Hyperalgesia. The report provides information on the therapeutic development based on the Hyperalgesia providing licensing, chemical, technology information and comparative analysis at various stages. DelveInsight’s Report is assessing the Hyperalgesia therapeutics by Monotherapy, Combination ...  |  read more...
USD 1,250
Hyperammonemia -Pipeline Insights, 2015
4/6/2015 | published by: DelveInsight
... under Hyperammonemia . The report provides information on the therapeutic development based on the Hyperammonemia  providing licensing, chemical, technology information and comparative analysis at various stages. DelveInsight’s Report is assessing the Hyperammonemia  therapeutics by Monotherapy, Combination ...  |  read more...
USD 1,250
Hyperoxaluria-Pipeline Insights, 2015
4/6/2015 | published by: DelveInsight
... under Hyperoxaluria. The report provides information on the therapeutic development based on the Hyperoxaluria providing licensing, chemical, technology information and comparative analysis at various stages. DelveInsight’s Report is assessing the Hyperoxaluria therapeutics by Monotherapy, Combination ...  |  read more...
USD 1,250
6  7  8  9    11    13  14  15